Effects of monthly dose and regular dosing of intravenous active vitamin d use on mortality among patients undergoing hemodialysis

Keyphrases

• Vitamin D 100%
• Maintenance Hemodialysis Patients 100%
• Dialysis Duration 80%
• Vitamin D Analogs 60%
• Cancer Mortality 40%
• Mortality Benefit 40%
• Medicare 20%
• Cardiovascular Mortality 20%
• Medicaid 20%
• Dialysis 20%
• Placebo 20%
• Randomized Controlled Trial 20%
• Infectious Diseases 20%
• All-cause Mortality 20%
• Cardiovascular Disease 20%
• End-stage Renal Disease 20%
• Cause-specific Mortality 20%
• Retrospective Cohort Study 20%
• Infection-related Mortality 20%
• Biological Mechanisms 20%
• Virus-associated Cancer 20%
• Baseline Characteristics 20%
• Reduced Mortality 20%
• Hospital Days 20%
• Hemoglobin Level 20%
• Baseline Period 20%
• Epoetin Alfa 20%
• Dialysis Initiation 20%
• Follow-up Time 20%
• Urea Reduction Ratio 20%
• Disease Database 20%
• Cause-specific Death 20%
• Vitamin D Dose 20%
• Time-varying Cox Proportional Hazard Models 20%
• Alpha Dose 20%
• Level Reduction 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Vitamin D 100%
• Hemodialysis 100%
• Malignant Neoplasm 25%
• Cohort Study 12%
• Randomized Controlled Trial 12%
• Placebo 12%
• Infection 12%
• All Cause Mortality 12%
• End Stage Renal Disease 12%
• Recombinant Erythropoietin 12%
• Cancer Mortality 12%
• Cardiovascular Disease 12%